{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:56:03Z","timestamp":1781279763779,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.vaccine.2012.06.073","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T04:40:26Z","timestamp":1341636026000},"page":"5464-5471","source":"Crossref","is-referenced-by-count":36,"title":["A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults"],"prefix":"10.1016","volume":"30","author":[{"given":"Birgit","family":"Thierry-Carstensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde Hylland","family":"Uhlving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Dalby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders M\u00f8rup","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.06.073_bib0005","unstructured":"Vaccine Assessment and Monitoring team of the Department of Vaccines and Biologicals. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. World Health Organization; 2003. Report No.: WHO\/V&B\/03.01."},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.06.073_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rationale for pertussis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2012.06.073_bib0015","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2012.06.073_bib0020","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.inf.0000160926.89577.3b","article-title":"Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives","volume":"24","author":"Cherry","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2012.06.073_bib0025","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/infdis\/jis178","article-title":"Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008\u20132010","volume":"205","author":"Octavia","year":"2012","journal-title":"J Infect Dis"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.06.073_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.vaccine.2006.07.023","article-title":"Comparison of pertussis surveillance systems in Europe","volume":"25","author":"Tozzi","year":"2007","journal-title":"Vaccine"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2012.06.073_bib0035","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(03)00107-5","article-title":"Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned","volume":"21","author":"Capiau","year":"2003","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.06.073_bib0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0022-3476(97)70247-6","article-title":"Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age","volume":"130","author":"Schmitt","year":"1997","journal-title":"J Pediatr"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2012.06.073_bib0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3476(96)70152-X","article-title":"Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants","volume":"129","author":"Schmitt","year":"1996","journal-title":"J Pediatr"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.06.073_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/14760584.6.1.47","article-title":"Acellular pertussis vaccines and the role of pertactin and fimbriae","volume":"6","author":"Poolman","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.06.073_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/INF.0b013e31818a8958","article-title":"Pertussis vaccine: a critique","volume":"28","author":"Robbins","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2012.06.073_bib0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4161\/hv.4.5.6008","article-title":"Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinations","volume":"4","author":"Vidor","year":"2008","journal-title":"Hum Vaccin"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2012.06.073_bib0065","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1016\/S0021-9258(17)43911-1","article-title":"Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase","volume":"258","author":"Sekura","year":"1983","journal-title":"J Biol Chem"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2012.06.073_bib0070","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0022-3476(88)80005-2","article-title":"Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide","volume":"113","author":"Sekura","year":"1988","journal-title":"J Pediatr"},{"issue":"September (41)","key":"10.1016\/j.vaccine.2012.06.073_bib0075","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1016\/j.vaccine.2008.07.033","article-title":"Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 23.5, 5 and 16 months of age","volume":"26","author":"Pietrzyk","year":"2008","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.06.073_bib0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","article-title":"Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera","volume":"105","author":"Kristiansen","year":"1997","journal-title":"APMIS"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.06.073_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0092-1157(74)90015-8","article-title":"Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration","volume":"2","author":"Miyamura","year":"1974","journal-title":"J Biol Stand"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.06.073_bib0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2008.12.004","article-title":"Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera","volume":"63","author":"Dalby","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2012.06.073_bib0095","series-title":"Vaccines","author":"Plotkin","year":"2008"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2012.06.073_bib0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.vaccine.2008.11.028","article-title":"Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19\u201364 years of age","volume":"27","author":"Blatter","year":"2009","journal-title":"Vaccine"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2012.06.073_bib0105","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1001\/jama.293.24.3003","article-title":"Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults","volume":"293","author":"Pichichero","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.06.073_bib0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparisons of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2012.06.073_bib0115","unstructured":"Blatter M. Open trial to evaluate the safety and immunogenicity of a fifth (booster) dose of diphtheria, tetanus, acellullar pertussis vaccine in healthy children. Unpublished; 1996:June. Report No.: Internal clinical trial report (014)."},{"key":"10.1016\/j.vaccine.2012.06.073_bib0120","unstructured":"Taranger J., Trollfors B. Safety and immunogenicity of combined vaccines against diphtheria, tetanus, pertussis and polio at six years of age. Unpublished; 1996:January. Report No.: Internal clinical trial report (007B)."},{"key":"10.1016\/j.vaccine.2012.06.073_bib0125","unstructured":"Gustafsson L, Hallander HO, Gothefors L. An immunogenicity and safety study of combined adsorbed tetanus, low dose diptheria and acellullar pertussis vaccine (TdaP5v and TdaP1v) given as a school-leaving booster to 14\u201315-year old adolescents primed with a five-component acellullar pertussis vaccine at 3, 5 and 12 months of age and a booster dose at 5 1\/2 years of age. Unpublished; 1011:September."},{"issue":"January (14)","key":"10.1016\/j.vaccine.2012.06.073_bib0130","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0264-410X(99)00415-6","article-title":"An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults","volume":"18","author":"Halperin","year":"2000","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.06.073_bib0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00006454-200004000-00003","article-title":"Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults","volume":"19","author":"Halperin","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.06.073_bib0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1542\/peds.2005-1759","article-title":"Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents","volume":"117","author":"Pichichero","year":"2006","journal-title":"Pediatrics"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2012.06.073_bib0145","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.vaccine.2005.11.024","article-title":"Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.06.073_bib0150","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0264-410X(00)00252-8","article-title":"A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults","volume":"19","author":"Turnbull","year":"2000","journal-title":"Vaccine"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2012.06.073_bib0155","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1016\/j.vaccine.2007.05.012","article-title":"Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine","volume":"25","author":"Zepp","year":"2007","journal-title":"Vaccine"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2012.06.073_bib0160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpeds.2006.06.016","article-title":"Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine","volume":"149","author":"Zepp","year":"2006","journal-title":"J Pediatr"},{"issue":"January (3\u20134)","key":"10.1016\/j.vaccine.2012.06.073_bib0165","first-page":"305","article-title":"Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults","volume":"22","author":"Van","year":"2004","journal-title":"Vaccine"},{"issue":"April (23\u201324)","key":"10.1016\/j.vaccine.2012.06.073_bib0170","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/S0264-410X(01)00029-9","article-title":"Immunogenicity and reactogenicity of a single dose of a diphtheria-tetanus-acellular pertussis component vaccine (DTaP) compared to a diphtheria-tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults","volume":"19","author":"Bartels","year":"2001","journal-title":"Vaccine"},{"issue":"April (20)","key":"10.1016\/j.vaccine.2012.06.073_bib0175","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0264-410X(99)00568-X","article-title":"A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults","volume":"18","author":"Van der Wielen","year":"2000","journal-title":"Vaccine"},{"issue":"May (28)","key":"10.1016\/j.vaccine.2012.06.073_bib0180","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","article-title":"Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults","volume":"23","author":"Grimprel","year":"2005","journal-title":"Vaccine"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2012.06.073_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/biol.1999.0187","article-title":"DTaP vaccines from north american vaccine (NAVA): composition and critical parameters","volume":"27","author":"Heron","year":"1999","journal-title":"Biologicals"},{"issue":"April (5)","key":"10.1016\/j.vaccine.2012.06.073_bib0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0264-410X(95)00230-X","article-title":"The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies","volume":"14","author":"Ibsen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.073_bib0195","doi-asserted-by":"crossref","unstructured":"Andersen PH. Kighoste 2010. EPI-NYT 11 A.D. 2010;October:Uge 42\u201343.","DOI":"10.1177\/112972981001103S05"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.06.073_bib0200","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/CVI.00270-10","article-title":"Seroprevalence of pertussis among Danish patients with cough of unknown etiology","volume":"17","author":"Dalby","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2012.06.073_bib0205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.vaccine.2008.11.102","article-title":"Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination","volume":"27","author":"McIntyre","year":"2009","journal-title":"Vaccine"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2012.06.073_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.10.025","article-title":"A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix) is immunogenic and well tolerated in adults","volume":"29","author":"Booy","year":"2010","journal-title":"Vaccine"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2012.06.073_bib0215","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/514338","article-title":"Immunity to pertussis 5 years after booster immunization during adolescence","volume":"44","author":"Edelman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"November (48)","key":"10.1016\/j.vaccine.2012.06.073_bib0220","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1016\/j.vaccine.2007.09.031","article-title":"Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine","volume":"25","author":"Barreto","year":"2007","journal-title":"Vaccine"},{"issue":"April (19)","key":"10.1016\/j.vaccine.2012.06.073_bib0225","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0264-410X(99)00534-4","article-title":"Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults","volume":"18","author":"Tran Minh","year":"2000","journal-title":"Vaccine"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2012.06.073_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/421943","article-title":"Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine","volume":"39","author":"Edelman","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2012.06.073_bib0235","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T13:28:17Z","timestamp":1743686897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12009541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":47,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0264410X12009541"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}